Prosecution Insights
Last updated: April 19, 2026

Amunix Pharmaceuticals Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18068872 COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS EMCH, GREGORY S 1678 Non-Final OA Dec 20, 2022
18073935 CYTOKINE CONJUGATES DENT, ALANA HARRIS 1643 Non-Final OA Dec 02, 2022
17621978 EGFR ANTIGEN BINDING FRAGMENTS AND COMPOSITIONS COMPRISING SAME CUNNINGCHEN, KATHLEEN MARY 1646 Non-Final OA Dec 22, 2021

Managing Amunix Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month